Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Neonatal Outcomes of Live Births After Blastocyst Biopsy in Preimplantation Genetic Testing Cycles

A Follow-up of 1721 Children

He, Hui; Jing, Shuang; Lu, Chang Fu; Tan, Yue Qiu; Luo, Ke Li; Zhang, Shuo Ping; Gong, Fei; Lu, Guang Xiu; Lin, Ge

Obstetrical & Gynecological Survey: November 2019 - Volume 74 - Issue 11 - p 656–657
doi: 10.1097/OGX.0000000000000748
GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES
Buy

(Abstracted from Fertil Steril 2019;112:82–88)

Blastocyst biopsy as a means of preimplantation genetic testing (PGT) continues to increase in popularity and might provide a greater number of viable cells per biopsy compared with cleavage-stage biopsy. The increased number of testable cells enables the application of comprehensive chromosome screening modalities including next-generation sequencing, as well as the combination of multiple genetic tests.

Institute of Reproduction and Stem Cell Engineering, Basic Medical College, Central South University (H.H., S.J., C.F.L., Y.Q.T., K.L.L., S.P.Z., F.G., G.X.L., G.L.); Key Laboratory of Stem Cell and Reproductive Engineering, Ministry of Health (C.F.L., Y.Q.T., G.X.L., G.L.); and Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, People's Republic of China (C.F.L., Y.Q.T., K.L.L., S.P.Z., F.G., G.X.L., G.L.)

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.